ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma

Technology
E-065-2002
Patent ID
E-065-2002-0-US-03
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
 
Publication Number
US-2005-0244828-A1
Application Number
10/514,910
IC
NCI
Date Filed
Date Issued
 
Patent PDF